Table 2 Survival probability calculated with Kaplan–Meier estimators and compared with the Breslow test.

From: Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model

Variable

Breslow test

Treatment

CG

THG

SG

HG

PCG

Mean ± SD

95% CI

Mean ± SD

95% CI

Mean ± SD

95% CI

Mean ± SD

95% CI

Mean ± SD

95% CI

Symmetry Index

0.000*

47.0 ± 11.8

23.8–70.2

96.0 ± 12.8

70.9–121.1

94.2 ± 15.9

62.9–125.4

104.1 ± 15.1

15.1–74.5

159.0 ± 10.3

138.9–179.1

Deviation

0.000*

44.8 ± 12.1

21.1–68.5

81.8 ± 14.7

52.9–110.6

55.6 ± 11.8

32.3–78.8

96.2 ± 16.3

64.2–128.1

138.0 ± 12.5

113.4–162.6

HVAS

0.000*

48.7 ± 12.4

25.4–73.9

66.1 ± 14.2

38.3–93.9

129.8 ± 13.4

103.5–156.1

117.0 ± 13.2

91.1–142.9

144.0 ± 11.6

121.2–166.8

PSS

0.015*

63.2 ± 17.2

29.6–96.8

90.2 ± 17.6

55.7–124.7

94.6 ± 16.4

62.5–126.7

142.6 ± 11.9

119.1–166.0

150.5 ± 9.7

130.9–169.1

PIS

0.000*

8.4 ± 0.4

7.7–9.0

118.6 ± 16.3

86.7–150.5

109.6 ± 17.3

75.8–143.2

114.0 ± 16.0

82.6–145.4

135.0 ± 10.6

114.2–155.8

LOAD

0.000*

40.7 ± 10.6

19.9–61.4

124.3 ± 15.9

93.1–155.5

123.8 ± 14.2

95.9–151.6

141.8 ± 11.6

119.2–164.4

120.0 ± 12.8

94.9–145.0

Stiffness

0.009*

64.7 ± 16.9

31.4–97.9

130.8 ± 11.6

108.1–153.5

111.2 ± 15.9

80.6–142.9

129.8 ± 13.9

102.6–157.0

141.0 ± 16.9

119.9–162.1

Function

0.000*

65.4 ± 13.4

39.2–91.6

112.6 ± 15.6

81.9–143.2

124.5 ± 15.4

94.2–154.8

168.0 ± 6.6

155.1–180.8

135.0 ± 9.4

116.5–153.5

Gait

0.001*

52.7 ± 14.6

23.9–81.4

117.0 ± 15.1

87.5–146.5

103.6 ± 15.7

72.8–134.4

115.5 ± 13.1

89.9–141.1

123.0 ± 12.5

98.5–147.5

QOL

0.004*

60.9 ± 15.0

31.4–90.4

119.3 ± 17.5

85.0–153.6

66.2 ± 17.5

31.8–100.6

125.6 ± 12.2

101.6–149.6

120.8 ± 13.1

95.1–146.5

COI

0.011*

52.7 ± 13.4

26.5–78.9

85.6 ± 15.9

54.4–116.9

78.1 ± 14.0

50.6–105.6

93.1 ± 16.7

60.3–125.9

138.0 ± 10.8

116.9–159.1

  1. See Table 1 for legend.
  2. *Indicates significance.